These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 22475271)

  • 1. Disposition and interaction of biotherapeutics in pediatric populations.
    Yanni S
    Curr Drug Metab; 2012 Sep; 13(7):882-900. PubMed ID: 22475271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric Dosing and Body Size in Biotherapeutics.
    Shi R; Derendorf H
    Pharmaceutics; 2010 Dec; 2(4):389-418. PubMed ID: 27721364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Quantitative Clinical Pharmacology in Pediatric Approval and Labeling.
    Mehrotra N; Bhattaram A; Earp JC; Florian J; Krudys K; Lee JE; Lee JY; Liu J; Mulugeta Y; Yu J; Zhao P; Sinha V
    Drug Metab Dispos; 2016 Jul; 44(7):924-33. PubMed ID: 27079249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacotherapy during pediatric extracorporeal membrane oxygenation: a review.
    Himebauch AS; Kilbaugh TJ; Zuppa AF
    Expert Opin Drug Metab Toxicol; 2016 Oct; 12(10):1133-42. PubMed ID: 27322360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric critical care pharmacodynamics.
    Dionne R; McManus C
    Crit Care Nurs Clin North Am; 1993 Jun; 5(2):367-75. PubMed ID: 8398042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations.
    Bartelink IH; Rademaker CM; Schobben AF; van den Anker JN
    Clin Pharmacokinet; 2006; 45(11):1077-97. PubMed ID: 17048973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Editorial: metabolism and drug-drug interaction potential of biotherapeutics.
    Li AP
    Curr Drug Metab; 2012 Sep; 13(7):881. PubMed ID: 22475272
    [No Abstract]   [Full Text] [Related]  

  • 8. Resurgence in the use of physiologically based pharmacokinetic models in pediatric clinical pharmacology: parallel shift in incorporating the knowledge of biological elements and increased applicability to drug development and clinical practice.
    Johnson TN; Rostami-Hodjegan A
    Paediatr Anaesth; 2011 Mar; 21(3):291-301. PubMed ID: 20497354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity and drug pharmacology: a review of the influence of obesity on pharmacokinetic and pharmacodynamic parameters.
    Smit C; De Hoogd S; Brüggemann RJM; Knibbe CAJ
    Expert Opin Drug Metab Toxicol; 2018 Mar; 14(3):275-285. PubMed ID: 29431542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allometry Is a Reasonable Choice in Pediatric Drug Development.
    Liu T; Ghafoori P; Gobburu JV
    J Clin Pharmacol; 2017 Apr; 57(4):469-475. PubMed ID: 27649629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric clinical pharmacology. A practical review.
    Udkow G
    Am J Dis Child; 1978 Oct; 132(10):1025-32. PubMed ID: 362892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential implications of DMET ontogeny on the disposition of commonly prescribed drugs in neonatal and pediatric intensive care units.
    Naji-Talakar S; Sharma S; Martin LA; Barnhart D; Prasad B
    Expert Opin Drug Metab Toxicol; 2021 Mar; 17(3):273-289. PubMed ID: 33256492
    [No Abstract]   [Full Text] [Related]  

  • 13. Causes and Consequences of Variability in Drug Transporter Activity in Pediatric Drug Therapy.
    Rodieux F; Gotta V; Pfister M; van den Anker JN
    J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S173-92. PubMed ID: 27385174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of drug disposition on the basis of its chemical structure.
    Stepensky D
    Clin Pharmacokinet; 2013 Jun; 52(6):415-31. PubMed ID: 23463353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Pharmacology Studies in Critically Ill Children.
    Thakkar N; Salerno S; Hornik CP; Gonzalez D
    Pharm Res; 2017 Jan; 34(1):7-24. PubMed ID: 27585904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sandwich-Cultured Hepatocytes as a Tool to Study Drug Disposition and Drug-Induced Liver Injury.
    Yang K; Guo C; Woodhead JL; St Claire RL; Watkins PB; Siler SQ; Howell BA; Brouwer KLR
    J Pharm Sci; 2016 Feb; 105(2):443-459. PubMed ID: 26869411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics.
    Fan J; de Lannoy IA
    Biochem Pharmacol; 2014 Jan; 87(1):93-120. PubMed ID: 24055064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing pediatric dosing: a developmental pharmacologic approach.
    Anderson GD; Lynn AM
    Pharmacotherapy; 2009 Jun; 29(6):680-90. PubMed ID: 19476420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ontogeny of Hepatic Drug Transporters and Relevance to Drugs Used in Pediatrics.
    Elmorsi Y; Barber J; Rostami-Hodjegan A
    Drug Metab Dispos; 2016 Jul; 44(7):992-8. PubMed ID: 26712821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Altered Drug Pharmacokinetics in Critically Ill Adults Receiving Extracorporeal Membrane Oxygenation.
    Ha MA; Sieg AC
    Pharmacotherapy; 2017 Feb; 37(2):221-235. PubMed ID: 27931091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.